Paul Brooks

Paul has over 20 years of experience in leading the successful development and commercialization of tools and services for academic, pharmaceutical, biotech, biopharma and molecular diagnostic markets.

He has held senior leadership positions in the USA and the UK, including Chief Commercial Officer and Executive Board member of Oxford Genetics, where he was responsible for developing and leading their commercial strategy when entering the CRISPR gene editing and Cell and Gene Therapy markets; Head of Discovery Services at Sigma-Aldrich, where he drove strategic transformation of the Pharmaceutical Research business unit to create a global leading product and service portfolio for drug discovery research; and Global Marketing Manager at Sigma-Aldrich, where he led product management teams in the development and commercialization of functional genomic technologies, including the world’s first commercial gene editing technology and custom cell line engineering service.